Two cases studies demonstrate whether crushed pazopanib is a feasible alternative for patients who cannot swallow the tablets whole.
Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.
Treatment-free remission maintained in 14 of 21 patients who discontinued tyrosine kinase inhibitors.
Using separate indirect medication adherence measures, researchers determined adherence rates for patients with MM treated with oral immunomodulatory therapy.
Researchers outline best practice for responding to anticancer therapy-induced hypersensitivity.
A review of outcomes in the MAVORIC trial for patients with CTCL who experienced treatment-related AEs.
Including chlorhexidine gluconate-impregnated dressing in central line bundle resulted in a dramatic change in central line infections.
Patient-completed pill and toxicity diaries were linked to medication adherence and timely management of AEs in clinical trial participants.
A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.
A report from a European working group of pediatric radiation oncologists focuses on recommendations for safer delivery of radiotherapy to children, especially in dose distributions involving spinal vertebrae.